Please login to the form below

Not currently logged in
Email:
Password:

Quantum Pharmaceutical hires Brian Fisher as commercial director

Joins from Alliance Healthcare to build relationships with the NHS and other customers

Quantum Pharmaceutical has appointed former head of sales at Alliance Healthcare Brian Fisher as its new commercial director.

Fisher will be tasked with developing relationships with customers such as pharmacies, wholesalers, hospitals and the NHS at the UK-based firm, which specialises in manufacturing and supplying unlicensed medicines and items that are difficult to source.

Brian Fisher - Quantum Pharmaceutical
Brian Fisher

The company said Fisher has extensive experience of the pharmaceutical industry as well as knowledge of the healthcare market across pharmacy, hospitals, dispensing doctors and manufacturer services.

This includes his two years at Alliance, as well as prior roles as UniChem, where he joined as business account manager before being promoted to head of hospitals and dispensing doctors.

Other previous experience includes five years at AAH Pharmaceuticals, where he was regional sales manager and then national account manager.

Commenting on his appointment, Fisher said: “I am delighted to have joined the board of directors at Quantum and I look forward to developing strategies and working with my colleagues to ensure Quantum Pharmaceutical leads the way in delivering great value and leading edge service excellence to the NHS, our customers and their patients."

16th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics